Cme Group Inc. financial data

Symbol
CME on Nasdaq
Location
20 S. Wacker Dr., Chicago, IL
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - Apr 30, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 102 % -0.39%
Debt-to-equity 409 % +4.74%
Operating Margin 64.9 % +4.9%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 70.4B USD +6.18%
Weighted Average Number of Shares Outstanding, Basic 360M shares +0.1%
Weighted Average Number of Shares Outstanding, Diluted 360M shares +0.11%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 6.28B USD +11.7%
Costs and Expenses 2.2B USD +2.85%
Operating Income (Loss) 4.08B USD +17.2%
Nonoperating Income (Expense) 593M USD -5.66%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4.67B USD +13.7%
Income Tax Expense (Benefit) 1.05B USD +14.6%
Earnings Per Share, Basic 10 USD/shares +13.4%
Earnings Per Share, Diluted 10 USD/shares +13.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.41B USD -2.2%
Marketable Securities, Current 114M USD -5.87%
Accounts Receivable, after Allowance for Credit Loss, Current 770M USD +22.6%
Other Assets, Current 462M USD -28.7%
Assets, Current 123B USD +26.9%
Property, Plant and Equipment, Net 371M USD -6.26%
Operating Lease, Right-of-Use Asset 224M USD -15.2%
Goodwill 10.5B USD +0.09%
Other Assets, Noncurrent 3.57B USD -3.47%
Assets 158B USD +19.5%
Accounts Payable, Current 100M USD -9.73%
Liabilities, Current 121B USD +26.3%
Deferred Income Tax Liabilities, Net 5.24B USD -1.45%
Operating Lease, Liability, Noncurrent 276M USD -17.1%
Other Liabilities, Noncurrent 721M USD -10.3%
Liabilities 131B USD +24.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -74.8M USD +13.1%
Retained Earnings (Accumulated Deficit) 4.69B USD -4.2%
Stockholders' Equity Attributable to Parent 27B USD -0.46%
Liabilities and Equity 158B USD +19.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.12B USD +25.1%
Net Cash Provided by (Used in) Financing Activities 19.2B USD +892%
Net Cash Provided by (Used in) Investing Activities -16M USD +29.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 20.3B USD +624%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 122B USD +27.3%
Deferred Tax Assets, Valuation Allowance 0 USD -100%
Deferred Tax Assets, Gross 142M USD +5.34%
Operating Lease, Liability 320M USD -16%
Depreciation 27.3M USD -9.3%
Payments to Acquire Property, Plant, and Equipment 14.2M USD -28.3%
Lessee, Operating Lease, Liability, to be Paid 379M USD -15.7%
Property, Plant and Equipment, Gross 1.41B USD +5.06%
Operating Lease, Liability, Current 43.5M USD -8.42%
Lessee, Operating Lease, Liability, to be Paid, Year Two 46.9M USD -12.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 54M USD -7.22%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -7.4M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 45.5M USD -10.3%
Deferred Tax Assets, Operating Loss Carryforwards 5.3M USD +55.9%
Preferred Stock, Shares Issued 4.6M shares 0%
Unrecognized Tax Benefits 252M USD -4.73%
Lessee, Operating Lease, Liability, to be Paid, Year Four 35.9M USD -27.5%
Operating Lease, Payments 73.6M USD +14.3%
Amortization of Intangible Assets 222M USD -1.47%
Deferred Tax Assets, Net of Valuation Allowance 142M USD +5.66%